,address1,address2,city,state,zip,country,phone,fax,website,industry,sector,longBusinessSummary,fullTimeEmployees,companyOfficers,compensationAsOfEpochDate,maxAge,priceHint,previousClose,open,dayLow,dayHigh,regularMarketPreviousClose,regularMarketOpen,regularMarketDayLow,regularMarketDayHigh,payoutRatio,beta,volume,regularMarketVolume,averageVolume,averageVolume10days,averageDailyVolume10Day,marketCap,fiftyTwoWeekLow,fiftyTwoWeekHigh,priceToSalesTrailing12Months,fiftyDayAverage,twoHundredDayAverage,trailingAnnualDividendRate,trailingAnnualDividendYield,currency,enterpriseValue,profitMargins,sharesOutstanding,bookValue,priceToBook,lastFiscalYearEnd,nextFiscalYearEnd,mostRecentQuarter,netIncomeToCommon,trailingEps,lastSplitFactor,lastSplitDate,enterpriseToRevenue,enterpriseToEbitda,exchange,quoteType,symbol,underlyingSymbol,shortName,longName,firstTradeDateEpochUtc,timeZoneFullName,timeZoneShortName,gmtOffSetMilliseconds,currentPrice,recommendationKey,totalCash,totalCashPerShare,ebitda,totalDebt,quickRatio,currentRatio,totalRevenue,revenuePerShare,returnOnAssets,returnOnEquity,grossProfits,freeCashflow,operatingCashflow,revenueGrowth,grossMargins,ebitdaMargins,operatingMargins,financialCurrency,trailingPegRatio
0,22121-17th Avenue SE,Suite 112,Bothell,WA,98021,United States,425-402-8400,425-806-2999,https://www.helixbiomedix.com,Biotechnology,Healthcare,"Helix BioMedix, Inc. operates as a specialty dermatology and consumer products skin health company in the United States. It develops and commercializes bioactive peptides, including anti-infective, anti-fungal, and anti-inflammatory peptides for the treatment of skin and wound infections, as well as for the prevention of staphylococcus aureus infections. The company also out-licenses its proprietary peptides to various entities. Helix BioMedix, Inc. was founded in 1988 and is headquartered in Bothell, Washington.",8,"{'maxAge': 1, 'name': 'Ms. Robin L. Carmichael', 'age': 65, 'title': 'Pres, CEO & Director', 'yearBorn': 1957, 'fiscalYear': 2011, 'totalPay': 304350, 'exercisedValue': 0, 'unexercisedValue': 0}",1325289600,86400,2,23.27,23.27,23.27,23.27,23.27,23.27,23.27,23.27,0.0,0.329183,12,12,4,10,10,5800094,22.0,26.0,2.8075182,23.1296,23.4764,0.0,0.0,USD,3640096,-1.25062,165718,6.939,3.3535092,1325289600,1356912000,1348963200,-2583671,-12.14,1:300,1357171200,1.762,-1.563,PNK,EQUITY,HXBM,HXBM,HELIX BIOMEDIX INC,"Helix BioMedix, Inc.",922372200,America/New_York,EDT,-14400000,23.27,none,216534,1.307,-2328767,0,1.182,2.329,2065915,12.465,-0.58999,-1.22531,1158031,-1083466,-1818997,0.188,0.68961996,-1.12723,-1.17303,USD,
1,22121-17th Avenue SE,Suite 112,Bothell,WA,98021,United States,425-402-8400,425-806-2999,https://www.helixbiomedix.com,Biotechnology,Healthcare,"Helix BioMedix, Inc. operates as a specialty dermatology and consumer products skin health company in the United States. It develops and commercializes bioactive peptides, including anti-infective, anti-fungal, and anti-inflammatory peptides for the treatment of skin and wound infections, as well as for the prevention of staphylococcus aureus infections. The company also out-licenses its proprietary peptides to various entities. Helix BioMedix, Inc. was founded in 1988 and is headquartered in Bothell, Washington.",8,"{'maxAge': 1, 'name': 'Kelly  Forsythe', 'title': 'Associate Director of Marketing', 'exercisedValue': 0, 'unexercisedValue': 0}",1325289600,86400,2,23.27,23.27,23.27,23.27,23.27,23.27,23.27,23.27,0.0,0.329183,12,12,4,10,10,5800094,22.0,26.0,2.8075182,23.1296,23.4764,0.0,0.0,USD,3640096,-1.25062,165718,6.939,3.3535092,1325289600,1356912000,1348963200,-2583671,-12.14,1:300,1357171200,1.762,-1.563,PNK,EQUITY,HXBM,HXBM,HELIX BIOMEDIX INC,"Helix BioMedix, Inc.",922372200,America/New_York,EDT,-14400000,23.27,none,216534,1.307,-2328767,0,1.182,2.329,2065915,12.465,-0.58999,-1.22531,1158031,-1083466,-1818997,0.188,0.68961996,-1.12723,-1.17303,USD,
